Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation
1998

Cytoplasmic p16 Protein in Breast Cancer and Tumor Growth

Sample size: 500 publication Evidence: high

Author Information

Author(s): R Emig, A Magener, V Ehemann, A Meyer, F Stilgenbauer, M Volkmann, D Wallwiener, H-P Sinn

Primary Institution: Universität Heidelberg

Hypothesis

Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumor proliferation.

Conclusion

Cytoplasmic accumulation of the p16 protein identifies a subset of highly malignant breast carcinomas with accelerated tumor proliferation.

Supporting Evidence

  • 33 out of 368 invasive breast cancers showed cytoplasmic p16 expression.
  • Median Ki67 index was 70% for tumors with cytoplasmic p16 expression.
  • Loss of estrogen and progesterone receptors was common in tumors with p16 overexpression.

Takeaway

Some breast cancer cells have too much of a protein called p16, which makes them grow faster and can be a sign that the cancer is more dangerous.

Methodology

The study evaluated p16 protein expression in breast carcinomas using immunohistochemistry, flow cytometry, and DNA sequencing.

Limitations

The study did not detect genetic alterations in the p16 gene in the analyzed cell lines.

Participant Demographics

The study included 368 invasive breast cancers, 52 non-invasive malignancies, and 88 locally recurring tumors.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication